Amgen

Yahoo Finance • 2 days ago

Drug Stock Rally Helps Push Dow and S&P 500 to Records

Pharma stocks climbed for a second session, extending gains that began after President Trump unveiled a direct-to-consumer website for Americans to buy drugs. Amgen and Merck both climbed more than 5%, to push the Dow Jones Industrial Aver... Full story

Yahoo Finance • 2 days ago

US Equity Indexes Rise as Fed Rate-Cut Certainty Jumps Amid Surprise Fall in Private Payrolls

US equity indexes rose on Wednesday amid gains in healthcare and increasing bets favoring an interes PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

Stocks Rally as Weak US Jobs News Reinforces Fed Rate Cut Hopes

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Wednesday closed up +0.34%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.co... Full story

Yahoo Finance • 3 days ago

Why Are Amgen (AMGN) Shares Soaring Today

What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed at increasing drug pro... Full story

Yahoo Finance • 3 days ago

Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins

US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Stocks Trim Losses as Drug Makers Rally

The S&P 500 Index ($SPX) (SPY) today is down -0.08%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.06%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.02%.  December E-mini S&P futures (ESZ25) are down -0.05%, and December E-mi... Full story

Yahoo Finance • 3 days ago

Eli Lilly, Amgen among gainers as Pfizer – U.S. drug pricing deal sparks “relief rally”

[Pharmaceuticals Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept Shares of Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]), Amgen (NASDAQ:AMGN [https://seekingalpha.com/symbol/AMGN]), and ot... Full story

Yahoo Finance • 3 days ago

Stocks making the biggest moves midday: Pfizer, Nike, Conagra, Corteva, GEO Group, Tesla, Reddit and more

Check out the companies making the biggest moves midday: Drug stocks — Shares of drugmakers rallied a second day as investors bet the industry will strike more deals with the Trump administration. On Tuesday, Pfizer received a three-year e... Full story

Yahoo Finance • 3 days ago

Amgen and Biogen settle patent dispute over Prolia and Xgeva biosimilars

[Amgen(Applied Molecular Genetics Inc.) Capability Center in Tampa.] JHVEPhoto/iStock Editorial via Getty Images * Biocon Biologics is set to roll out biosimilars targeting Amgen’s (NASDAQ:AMGN [https://seekingalpha.com/symbol/AMGN]) bl... Full story

Yahoo Finance • 3 days ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

Company Logo The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class m... Full story

Yahoo Finance • 3 days ago

Immatics appoints industry veteran as CFO

* Immatics N.V. (NASDAQ:IMTX [https://seekingalpha.com/symbol/IMTX]) has appointed Venkat Ramanan as chief financial officer, effective immediately. * Ramanan brings 25+ years of biopharma finance experience, with leadership roles at S... Full story

Yahoo Finance • 3 days ago

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff

Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday. Continue Reading View Comments... Full story

Yahoo Finance • 3 days ago

Immatics Appoints Venkat Ramanan as Chief Financial Officer

https://immatics.com/ Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, to... Full story

Yahoo Finance • 3 days ago

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.

The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers. Continue Reading View Comments... Full story

Yahoo Finance • 3 days ago

Stocks Settle Higher as Drug Makers and Chip Stocks Rally

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Tuesday closed up +0.41%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/... Full story

Yahoo Finance • 4 days ago

Trump seeks more drug pricing deals similar to Pfizer’s

[U.S. President Donald Trump Visits Scotland For Rounds Of Golf And Trade Talks] Christopher Furlong Announcing an agreement with Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]) to offer all brand-name drugs marketed by the compan... Full story

Yahoo Finance • 4 days ago

Dow Movers: AMZN, AMGN

In early trading on Tuesday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.9%. Year to date, Amgen registers a 6.1% gain. And the worst performing Dow component thus fa... Full story

Yahoo Finance • 5 days ago

Validea Detailed Fundamental Analysis - AMGN

Below is Validea's guru fundamental report for AMGEN, INC. (AMGN). Of the 22 guru strategies we follow, AMGN rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model see... Full story

Yahoo Finance • 5 days ago

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency

​Amgen Inc. (NASDAQ:AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Amgen Inc.’s (NASDAQ:AMGN) and AstraZeneca’s Tezspire received a positive recommendation from the European Medicines A... Full story

Yahoo Finance • 5 days ago

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs

We recently compiled a list of the 12 Most Undervalued Dow Stocks to Buy According to Analysts. Amgen Inc. is one of them. Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company specializing in innovative therapeutics for complex cance... Full story